From Prevention to Intervention – Cardiovascular Updates with a Focus on Women

2023 CME Conference References

Brown, H. L., Warner, J. J., Gianos, E., Gulati, M., Hill, A. J., Hollier, L. M., Rosen, S. E., Rosser, M. L., & Wenger, N. K. (2018). Promoting Risk Identification and Reduction of Cardiovascular Disease in Women Through Collaboration With Obstetricians and Gynecologists: A Presidential Advisory From the American Heart Association and the American College of Obstetricians and Gynecologists. Circulation, 137(24), e843-e852.

Elis A. Current and future options in cholesterol lowering treatments. Eur J Intern Med. 2023 Jun;112:1-5. doi: 10.1016/j.ejim.2023.02.010. Epub 2023 Feb 20. PMID: 36813611.

Gianos, E., Lau, E. S., El Khoudary, S. R., & Guyton, J. R. (2023). JCL Roundtable: Lipidology and Women’s Health. J Clin Lipidol, 17(1), 4-11.

Gulersen, M., Jeganathan, S., Hemphill, J., Grayver, E., Gajer, R., Blitz, M. J., Rochelson, B., & Pessel, C. (2022). Sociodemographic factors associated with patient follow-up after implementation of a CardioObstetrics program. American Journal of Obstetrics & Gynecology, 226(1), S726.

Henry, S., Vaidean, G., Rege, R., & Gianos, E. (2023). Common origins and shared opportunities for breast cancer and cardiovascular disease prevention. Heart, heartjnl-2022-321710.

Lundberg, G. P., Mehta, L. S., Sanghani, R. M., Patel, H. N., Aggarwal, N. R., Aggarwal, N. T., Braun, L. T., Lewis, S. J., Mieres, J. H., Wood, M. J., Harrington, R. A., & Volgman, A. S. (2018). Heart Centers for Women. Circulation, 138(11), 1155-1165.

Mehta, L. S., Velarde, G. P., Lewey, J., Sharma, G., Bond, R. M., Navas-Acien, A., Fretts, A. M., Magwood, G. S., Yang, E., Blumenthal, R. S., Brown, R.-M., & Mieres, J. H. (2023). Cardiovascular Disease Risk Factors in Women: The Impact of Race and Ethnicity: A Scientific Statement From the American Heart Association. Circulation, 147(19), 1471-1487.

Peterson, K. A., Kaur, G., Gianos, E., Mookherjee, S., Poli, K. A., Sidhu, M. S., & Lyubarova, R. (2022). Challenges in Optimizing Lipid Management in Women. Cardiovasc Drugs Ther, 36(6), 1197-1220.

Wilkinson MJ, Lepor NE, Michos ED. Evolving Management of Low-Density Lipoprotein Cholesterol: A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum. J Am Heart Assoc. 2023 Jun 1:eJAHA2022028892. doi: 10.1161/JAHA.122.028892. Epub ahead of print. PMID: 37260036.

Evolving Management of Low‐Density Lipoprotein Cholesterol_ A Personalized Approach to Preventing Atherosclerotic Cardiovascular Disease Across the Risk Continuum JCl Roundtable_Lipidology and Womens Health Current and Future Options in Cholesterol Lowering Treatments Cardiovascular Disease Risk Factors in Women Promoting Risk Identificatin and Reduction of CV Disease in Women Through OBGYNs_Circulation Heart Centers for Women

Challenges in Optimizing Lipid Management in Women_Cardiovasc Drugs Therapy